header logo image

14th Annual Personalized Medicine Conference November 14 …

August 5th, 2018 4:49 pm

The 14th Annual Personalized Medicine Conference: Preparing for the New Possible will convene the worlds leading researchers, investors, industry executives, policy experts, payers, clinicians, and patient advocates to define the landscape and outlook for personalized medicine in science, business, and policy. Participants will examine the infrastructure and business strategies necessary to overcome scientific obstacles, optimize public policies, and change embedded medical norms as we seek to accelerate investment in and adoption of personalized medicine.

Featured Speakers

Amy P. Abernethy, M.D., Ph.D.

Chief Medical Officer, Chief Scientific Officer

Flatiron Health

Donna R. Cryer, J.D.

President, CEO

Global Liver Institute

Luba Greenwood, J.D.

Strategic Business Development and Corporate Ventures

Verily, an Alphabet Company

David King, J.D.

Chairman, CEO

LabCorp

Daniel P. ODay, M.B.A.

Chief Executive Officer

Roche Pharmaceuticals

Ellen V. Sigal, Ph.D.

Chairperson, Founder

Friends of Cancer Research

Ralph Snyderman, M.D.

James B. Duke Professor of Medicine

Duke University

Keith Stewart, M.B., Ch.B.

Carlson and Nelson Endowed Director, Center for Individualized Medicine

Mayo Clinic

Liisa-Maria Voipio-Pulkki, M.D., Ph.D.

Director General, Chief Medical Officer, Ministry of Social Affairs and Health

Finland

View full List of Speakers

Continued here:
14th Annual Personalized Medicine Conference November 14 ...

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick